Green Leaf Manufacturing

Green Leaf Pharma is a biopharmaceutical manufacturing company that specializes in the development of active pharmaceutical ingredients and finished dosage forms using its proprietary Biopharming technology. This innovative platform utilizes transgenic plants, specifically tobacco, to synthesize recombinant proteins and monoclonal antibodies, offering a scalable and cost-effective alternative to traditional mammalian cell culture. The company's current pipeline focuses on the development of biosimilars for oncology, autoimmune disorders, and orphan diseases, as well as medical devices based on recombinant human collagen. Green Leaf Pharma operates through research centers in Russia and Israel and aims to establish full-cycle GMP-compliant production facilities to serve global markets.